Home › NDC Lookup › Ingredients › Niacinamide, Adenosine › 77964-0004-01
🧴image loading
(from DailyMed)

FOASU Pink Y s RecoveryCream niacinamide, adenosine .04 g/100mL; 2 g/100mL Cream, 50 mL

by HANSCOS Co.,Ltd. · 50 mL in 1 CONTAINER (77964-004-01)
NDC 77964-0004-01
🏷️ FDA NDC (as labeled) 77964-004-01 billing pads the product segment with a zero
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 77964-004-01
Product NDC 77964-004
11-digit billing NDC 77964000401
UNII K72T3FS567, 25X51I8RD4
UPC 8809579912682
SPL Set ID d8fa2f3f-52e1-47ef-e053-2995a90a2a94
Established class (EPC) Adenosine Receptor Agonist
Mechanism of action Adenosine Receptor Agonists
DEA schedule Non-controlled
Marketing category UNAPPROVED DRUG OTHER
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2022-02-27
Route TOPICAL
Dosage form CREAM
Substance ADENOSINE; NIACINAMIDE
Why two NDCs? The FDA registers this code as 77964-004-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 77964-0004-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerHANSCOS Co.,Ltd.
Labeler code77964
First marketedFeb 2022
Product typeHuman Otc Drug
Portfolio5 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

FOASU Pink Y's RecoveryCream is a topical cream containing niacinamide and adenosine. Niacinamide, also called vitamin B3, is commonly included in skincare products for its role in supporting skin barrier function and reducing irritation. Adenosine is typically used in cosmetic and personal care formulations as it may help support skin hydration and appearance. This product is marketed as an unapproved drug and has not received FDA approval.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
FOASU Pink Y s RecoveryCream .04 g/100mL; 2 g/100mLthis 77964-0004-01 HANSCOS 50 ml — — FDA listed —
Derladie Witch Hazel Perfect Vitamin Gelcream .04 g/100mL; 2 g/100mL 82083-0001-01 LAON 55 ml — — FDA listed —
Reoganic Body Firming StretchCream .04 g/100mL; 2 g/100mL 82083-0026-01 LAON 200 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2022
On the market since
Feb 2022
📍
2026
Currently FDA-listed
4 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
77964-0004-01 You're viewing this 50 mL in 1 CONTAINER (77964-004-01) 2022-02-27 Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product Marketed without an FDA application

Listed without an FDA application

This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Drug Other". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 77964-004-01, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 77964-0004-01, written without dashes as 77964000401. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 77964-0004-01, the first segment (77964) is the labeler code FDA assigned to HANSCOS Co.,Ltd.; the middle segment (0004) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by HANSCOS Co.,Ltd.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
HANSCOS Co.,Ltd. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 7 words ▾

Use apply proper amount to the skin

⏱️ Dosage and Administration 5 words ▾

Directions for external use only

⚠️ Warnings 53 words ▾

Warnings For external use only 1) Please consult your doctor if you experience side effects such as swelling, itching, or reddening on the area where you applied this product 2) Do not apply on wounds or cuts. 3) Do not store where children may reach, and avoid keeping it exposed to direct sunlight.

🧪 Active Ingredient 4 words ▾

Active ingredient niacinamide, adenosine

🧪 Inactive Ingredients 170 words ▾

Inactive ingredients YEAST FERMENT EXTRACT BUTYLENE GLYCOL WATER PHENYL TRIMETHICONE 1,2-HEXANEDIOL CYCLOPENTASILOXANE PEG-240/HDI COPOLYMER BIS-DECYLTETRADECETH-20 ETHER ALCOHOL ARGANIA SPINOSA KERNEL OIL GLYCERYL GLUCOSIDE GLYCERYL STEARATE GLYCERYL CAPRYLATE PEG-150 DISTEARATE CETYL ALCOHOL DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER GLYCERIN ECTOIN POLYSORBATE 80 POLYACRYLATE-13 PROPANEDIOL ALLANTOIN BETAINE OENOTHERA BIENNIS (EVENING PRIMROSE) OIL PANTHENOL CITRUS MEDICA LIMONUM (LEMON) FRUIT OIL STEARYL ALCOHOL XANTHAN GUM POLYISOBUTENE TOCOPHERYL ACETATE DIPROPYLENE GLYCOL OCTYLDODECANOL CENTELLA ASIATICA EXTRACT DISODIUM EDTA MYRISTYL ALCOHOL SODIUM HYALURONATE PEG-8 POLYSORBATE 20 SORBITAN ISOSTEARATE ECLIPTA PROSTRATA EXTRACT HOUTTUYNIA CORDATA EXTRACT PASSIFLORA INCARNATA EXTRACT PHYLLOSTACHYS NIGRA LEAF EXTRACT POLYGONUM MULTIFLORUM ROOT EXTRACT URTICA DIOICA (NETTLE) EXTRACT JASMINUM OFFICINALE (JASMINE) EXTRACT LILIUM TIGRINUM EXTRACT ROSE EXTRACT CAMELLIA SINENSIS LEAF EXTRACT FREESIA REFRACTA EXTRACT IRIS ENSATA EXTRACT LEONTOPODIUM ALPINUM FLOWER/LEAF EXTRACT NELUMBO NUCIFERA FLOWER EXTRACT HYDROGENATED LECITHIN CAPRYLYL GLYCOL PUNICA GRANATUM EXTRACT HELIANTHUS ANNUUS (SUNFLOWER) SEED EXTRACT PPG-1-PEG-9 LAURYL GLYCOL ETHER HEDERA HELIX (IVY) LEAF/STEM EXTRACT ETHYLHEXYLGLYCERIN CLITORIA TERNATEA FLOWER EXTRACT GARCINIA MANGOSTANA PEEL EXTRACT CERAMIDE NP PHYTIC ACID SODIUM POLYACRYLATE BETA-GLUCAN CYANOCOBALAMIN ACETYL HEXAPEPTIDE-8 COPPER TRIPEPTIDE-1 PALMITOYL PENTAPEPTIDE-4

🎯 Purpose 3 words ▾

Purpose skin protectant

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 77964-0003-01 · HANSCOS 77964-0005-01 · HANSCOS →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.